Curaleaf Reaffirms Offer to Aurora Cannabis
Curaleaf has publicly reaffirmed its offer to Aurora Cannabis, stating it remains the best path to value creation for shareholders. The company highlights its offer includes a 45% premium and significant future upside.
Cannabis company Curaleaf has publicly reaffirmed its interest in Aurora Cannabis, maintaining that its offer represents the most effective route to shareholder value creation. Curaleaf's proposal includes a 45% premium over Aurora's current share value and provides an opportunity for Aurora shareholders to participate in the upside of a substantially larger and more diversified cannabis platform.
The company issued a response to Aurora's earlier circular, in which Aurora had questioned Curaleaf's terms. Curaleaf asserts that its offer delivers immediate value to Aurora's shareholders while also enabling them to benefit from the future growth of a significantly expanded and diversified cannabis operation. Curaleaf also aimed to address perceptions regarding Aurora's financial standing, referencing Aurora's statement about a debt-free balance sheet.
Curaleaf argues that a combination would establish an industry-leading entity with extensive geographical reach and a comprehensive product portfolio. This consolidation, the company suggests, would enhance its competitive position in a rapidly evolving market and better equip it to meet escalating consumer demand across various segments.
The company stated it is continuing its dialogue with Aurora and believes its offer remains the most compelling option for the shareholders of both entities over the long term. Curaleaf has not provided further details on the progress of negotiations or any potential revised terms.